Conformal Radiation Therapy for Pediatric Patients with Low-Grade Glioma: Results from the Children’s Oncology Group Phase II Study XXXX

We studied the rates of marginal relapse, progression-free survival, and overall survival in 85 children with pediatric low-grade glioma receiving conformal radiation therapy with a clinical target volume (CTV) margin of 0.5 cm in the Children's Oncology Group trial XXXX. The progression-free and overall survival rates were acceptable and marginal relapse was not observed with this treatment strategy. Limiting the CTV may reduce the risk of treatment-related complications.

https://ift.tt/2FeDXDN